skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Screening for Hepatocellular Carcinoma in Adults at Increased Risk: A Systematic Review

Click for list of published reports
Click for topic nomination form
Click for list of reports in progress

 Screening for Hepatocellular Carcinoma in Increased Risk Adults: A Systematic Review

Recommended citation:
Landsteiner A, Ullman K, Langsetmo L, Zerzan N, Kalinowski C, Haglund J, Wilt TJ. Screening for Hepatocellular Carcinoma in Adults at Increased Risk: A Systematic Review. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. VA ESP Project #09-009; 2023.



Download PDF: Complete Report, Executive Summary, Report, Appendices

Takeaway

Despite a preponderance of observational studies, evidence was very uncertain regarding the effectiveness and harms of hepatocellular carcinoma (HCC) screening in adults at increased risk. Evidence was also very uncertain regarding comparative effects of different screening strategies including imaging modalities, intervals, and biomarkers.

Context

HCC is common and a leading cause of cancer deaths. Individuals at increased HCC risk and considered targets for screening include those with cirrhosis or hepatitis B infection. Screening is primarily with imaging (ultrasound, computer tomography, or magnetic resonance imaging) with or without alpha-fetal protein (AFP). Uncertainty exists regarding screening effectiveness, harms, costs, and burden as well as comparative effectiveness of screening strategies. We conducted a systematic review to examine the effectiveness of screening versus no screening and comparative effectiveness and harms of different screening modalities, intervals, and biomarkers among individuals at increased risk of developing HCC.

Key Findings

The available evidence is substantial in quantity but has important methodological limitations precluding reliable assessment of screening effectiveness and harms. Most studies analyzed only individuals already having HCC, thus missing the intended target population for screening. Major methodological issues that limit certainty include a combination of lead- and length-time bias and little controlling for confounders known to affect receipt of screening and survival. We found very little data from studies that could provide more reliable information (cohort, case-control, randomized controlled trials [RCTs]) regarding screening among individuals at risk for HCC. Among these studies, methodological concerns or inconsistent findings severely limited conclusions. A VA RCT is comparing ultrasound+AFP with abbreviated MRI but will not address screening effectiveness. Evidence gaps could be closed with RCTs comparing screening with no screening, and higher methodological quality observational studies. Until methodologically higher quality studies are completed, the current uncertainty challenges HCC screening implementation and patient-clinician decision-making.

See also

Screening for Hepatocellular Carcinoma in Adults at Increased Risk - Management eBrief


Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.